SCHEMBL24291456

SCHEMBL24291456

O=C(NCc1ccccc1)c1cccc(NC(=O)c2ccc([N+](=O)[O-])o2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 7/20 0.71
▸ MAPK1 P28482 2/20 0.71
▸ PAX8 Q06710 3/20 0.64
▸ MEN1 O00255 3/20 0.64
▸ KMT2A Q03164 3/20 0.64
▸ JAK2 O60674 2/20 0.63
▸ MAPT P10636 3/20 0.57
▸ HTT P42858 4/20 0.56
▸ ALDH1A1 P00352 2/20 0.56
▸ HPGD P15428 1/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ DDIT3 P35638 1/20 0.56
▸ RAB9A P51151 2/20 0.55
▸ KDM4E B2RXH2 1/20 0.55
▸ NFKB1 P19838 2/20 0.54
▸ NFKB2 Q00653 2/20 0.54
▸ RELA Q04206 2/20 0.54
▸ NPC1 O15118 2/20 0.54
▸ MITF O75030 1/20 0.54
▸ GAA P10253 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25005417 0.88 JAK2 (0.67) LMNAMAPK1PAX8MEN1KMT2A
SCHEMBL25005574 0.85 JAK2 (0.64) LMNAMAPK1PAX8MEN1KMT2A
SCHEMBL29462179 0.84 JAK2 (0.72) LMNAMAPK1PAX8MEN1KMT2A
SCHEMBL22822605 0.84 JAK2 (0.72) LMNAMAPK1PAX8MEN1KMT2A
SCHEMBL22804228 0.83 JAK2 (0.75) LMNAMAPK1PAX8MEN1KMT2A
SCHEMBL25006066 0.83 JAK2 (0.61) LMNAMAPK1PAX8MEN1KMT2A
SCHEMBL15319165 0.83 LMNA (0.76) LMNAMAPK1MEN1KMT2AHTT
SCHEMBL22822771 0.82 JAK2 (0.70) LMNAMAPK1PAX8MEN1KMT2A
SCHEMBL1520209 0.82 DDIT3 (0.78) LMNAPAX8MEN1KMT2AJAK2
SCHEMBL22804226 0.81 JAK2 (0.67) LMNAMAPK1PAX8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112107568-B Diaryl amide compound and application thereof 北京龙嘉博创医药科技有限公司 2022-03-25 — — CN claimed
CN-112107568-A Diaryl amide compound and application thereof 北京大学 2020-12-22 — — CN claimed
US-20230045031-A1 Diarylamide Compound and Application Thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2023-02-09 — — US disclosed
EP-3984534-A1 DIARYLAMIDE COMPOUND AND APPLICATION THEREOF Peking University (CN) 2022-04-20 — — EP disclosed
CN-112107568-B Diaryl amide compound and application thereof 北京龙嘉博创医药科技有限公司 2022-03-25 — — CN disclosed
CN-112107568-A Diaryl amide compound and application thereof 北京大学 2020-12-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230045031-A1 Diarylamide Compound and Application Thereof SLC14A1, SLC28A1, SLC28A2 LMNA 3332/4885MAPK1 852/4885PAX8 2906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback